India CRO Market Research Report- Forecast to 2027

India CRO Market Information, by Services Type (Clinical trials, Product Development, Process Development, Post-Marketing Surveillance, Quality Monitoring and Others); by Therapeutic Application (Oncology, Cardiovascular, Neurology, Nephrology and Urology, and Others) and by End Users (Pharmaceutical/biopharmaceutical Companies, Medical devices Companies and Academic Institutes) - Forecast till 2027

ID: MRFR/Pharma/2151-HCR | February 2021 | Region: Global | 70 pages

Please note that the assessment period of report has been updated from 2013- 2022 to 2020-2027. Cordially fill Sample form for updated data.

Market Synopsis of India CRO Market:


Market Scenario:


A contract research organization (CRO) provides support to the pharmaceutical, biotechnology, and medical device industries for specific services on a contract basis. The services may be clinical research, product development such as drug development or process development such as bio analytical assay development. A CRO may also provide management services such as clinical trials management, and pharmacovigilance.


India is emerging as a top destination for contract research organizations for the following reasons



  • India’s acceptance of International guidelines and intellectual property rights

  • Presence of diverse types of climatic conditions thus allowing stability studies to be performed with ease in one destination

  • Educated and accessible human resource in India

  • Presence of diverse ethnic pool thus enabling diverse sample for clinical trials

  • Low operational cost due to cheap human resource

  • Availability of largest pool of patients and large hospitals


The other factors favoring the market are efforts by the regulatory authorities such as Director Controller General of India (DCGI), Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) to create an amenable climate for research in India.


The market constraints are growing concern for security especially data security and patient security, lack of collaboration between universities and industry etc. The compromises done by some Indian CROs on ethical and technical standards are the greatest market threat.


Taking all factors into consideration, we expect the India CRO market to reach around $986.9 Million from $500 Million in 2017, by the end of the forecast period at a CAGR of ~12.00%.


Study Objectives India CRO Market:



  • To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Indian CRO market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments for India CRO market

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by service type, by therapeutic applications, by end users and other sub segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

India CRO Market Share by End Users, 2017 (%):



Key Players for India CRO Market:

Some of the key players in this market are: Quintiles IMS Holdings, Inc., Syngene, Pharmaceutical Product Development, LLC., Siro Clinpharm, Clininvent Research Pvt. Ltd., VIMTA, Bilcare Limited, Aizant Drug Research Solutions Private Limited, Piramal Pharma Solutions, Synapse Labs Pvt Limited, Eurofins Scientific, Laurus Labs., Neuland Laboratories Ltd, and PAREXEL International Corporation


Segments:


India CRO market has been segmented on the basis of service types which comprises clinical trials, product development, process development, post-marketing surveillance, quality monitoring and others. On the basis of therapeutic application; market is segmented into oncology, cardiovascular, neurology, nephrology and urology, and others. On the basis of end users; market is segmented into pharmaceutical/biopharmaceutical companies, medical devices companies and academic institutes.


Regional Analysis of India CRO Market:


The healthcare sector of India is divided between differential geographic regions and states. The South India and western India account for a major share of the Indian CRO market. However of late the CRO industry is shifting to the North. The reasons for this shift is the concentration of regulatory authority such as Director Controller General of India (DCGI) office, Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) etc. Also the costs are lower in North India and the genetic pool is more diverse.
Intended Audience



  • Contract Research Organizations

  • Medical Devices Suppliers

  • Private Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Government Research Laboratories

  • Contract Manufacturing Organizations


The report for India CRO Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Frequently Asked Questions (FAQ) :


The India CRO market is projected to grow at a 12% CAGR between 2013-2022.

The India CRO market is predicted to touch USD 986.9 million by 2022.

Western India and South India are predicted to lead the India CRO market.

Major applications of the India CRO Market include urology, nephrology, neurology, cardiovascular, and oncology.

Data and patient security issues may limit market growth.

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 India CRO Market, by Service Type

5.1 Introduction

5.1.1 Clinical trials

5.1.2 Product Development

5.1.3 Process Development

5.1.4 Post-Marketing Surveillance

5.1.5 Quality Monitoring

5.1.6 Others

6 India CRO Market, by Therapeutic Application

6.1 Introduction

6.1.1 Oncology

6.1.2 Cardiovascular

6.1.3 Neurology

6.1.4 Nephrology and Urology

6.1.5 Cardiovascular

6.1.6 Others

7 India CRO Market, by End User

7.1 Introduction

7.1.1 Pharmaceutical/biopharmaceutical companies

7.1.3 Medical devices Companies

7.1.4 Academic Institutes

8 India CRO Market, by Country

8.1 Introduction

8.2 North India

8.3 South India

8.4 East India

8.5 West India

8.6 Central India

9 Company Landscape

9.1 Introduction

9.1.1 Mergers Acquisitions

9.1.2 Collaborations

9.1.3 Release/New Product Launches

9.1.4 Other (Expansion, Updates, Partnership)

10 Company Profile

10.1 Quintiles IMS Holdings, Inc.

10.1.1 Company Overview

10.1.2 Product/Business Segment Overview

10.1.3 Financials

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Syngene, Pharmaceutical Product Development, LLC

10.2.1 Overview

10.2.2 Product/Business Segment Overview

10.2.3 Financials

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Siro Clinpharm

10.3.1 Overview

10.3.2 Product/Business Segment Overview

10.3.3 Financials

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.4 VIMTA, Bilcare Limited

10.4.1 Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financials

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.5 Aizant Drug Research Solutions Private Limited

10.5.1 Overview

10.5.2 Product/Business Segment Overview

10.5.3 Financials

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Piramal Pharma Solutions

10.6.1 Overview

10.6.2 Product/Business Segment Overview

10.6.3 Financials

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Synapse Labs Pvt Limited

10.7.1 Overview

10.7.2 Product/Business Segment Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Eurofins Scientific

10.8.1 Overview

10.8.2 Product/Business Segment Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Laurus Labs., Neuland Laboratories Ltd

10.9.1 Overview

10.9.2 Product/Business Segment Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 PAREXEL International Corporation

10.10.1 Overview

10.10.2 Product/Business Segment Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Others

11 Appendix

List of Tables

TABLE 1 INDIA CRO MARKET, 2020-2027 (USD MILLION)

TABLE 2 INDIA CRO MARKET, BY SERVICE TYPE, 2020-2027 (USD MILLION)

TABLE 3 INDIA CRO MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)

TABLE 4 INDIA CRO MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 5 INDIA CRO MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 INDIA CRO MARKET, BY SERVICE TYPE

FIGURE 4 INDIA CRO MARKET, BY THERAPEUTIC APPLICATION

FIGURE 5 INDIA CRO MARKET, BY END USER

FIGURE 6 INDIA CRO MARKET, BY REGION

FIGURE 7 INDIA CRO MARKET: COMPANY SHARE ANALYSIS, 2020 (%)